Antibody response after vaccination with 23-valent pneumococcal polysaccharide vaccine
Not Applicable
- Conditions
- Chronic lung disease
- Registration Number
- JPRN-UMIN000014254
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have already received pneumococcal vaccine 2) Patients who have fever 3) Allergy against vaccine contents 4) Pregnancy 5) When the doctor decides the patient's condition is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti pneumococcal capsular polysaccharide IgG antibody
- Secondary Outcome Measures
Name Time Method